| Literature DB >> 31656681 |
George Cheng1, Amit Mahajan2, Scott Oh3, Sadia Benzaquen4, Alexander Chen5.
Abstract
Endobronchial ultrasound (EBUS) and transbronchial needle aspiration (TBNA) have changed the landscape of pulmonology. Mediastinal structures beyond the confines of airway walls are visualized in real-time with EBUS, leading to improved accuracy of tissue sampling and diagnostic yield. With the development of various needle sizes ranging from 25-G to 19-G, the sampling of lymph nodes is becoming easier and more commonplace. Yet, certain conditions such as sarcoidosis and lymphoma may still be difficult to diagnose via EBUS-TBNA. Furthermore, in the age of targeted therapy, there are more demands on EBUS-TBNA samples for molecular marker testing and next-generation sequencing. Here, we present a complementary methodology, EBUS-guided intranodal forceps biopsy (EBUS-IFB), for tissue acquisition that may help address these deficiencies. Specifically, we aim to propose indications, contraindications, outline approaches in performing IFB, and provide an overview of the data for this complementary technique. 2019 Journal of Thoracic Disease. All rights reserved.Entities:
Keywords: Endobronchial ultrasound (EBUS); intranodal forceps biopsy (IFB); lymphadenopathy; miniforceps biopsy; transbronchial needle aspiration (TBNA)
Year: 2019 PMID: 31656681 PMCID: PMC6790451 DOI: 10.21037/jtd.2019.08.106
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895